XML 46 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
Intangible Assets (Details)
$ in Thousands, £ in Millions, $ in Millions
 1 Months Ended 3 Months Ended 9 Months Ended
Aug. 31, 2022
USD ($)
Jul. 31, 2022
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Mar. 31, 2023
USD ($)
May 31, 2022
USD ($)
May 31, 2022
GBP (£)
May 31, 2022
CAD ($)
Recognized Intangible Assets [Abstract]                    
Remaining weighted average estimated useful lives     14 years 9 months 18 days   14 years 9 months 18 days          
Gross amount     $ 166,471   $ 166,471   $ 152,629      
Less: accumulated amortization     (16,056)   (16,056)   (7,748)      
Net book value     150,415   150,415   $ 144,881      
Future amortization expense, remainder of 2024     2,500   2,500          
Future amortization expense, 2025     10,100   10,100          
Future amortization expense, 2026     10,100   10,100          
Future amortization expense, 2027     10,100   10,100          
Future amortization expense, 2028     10,100   10,100          
Future amortization expense, thereafter     107,500   107,500          
Cost of Revenues [Member]                    
Recognized Intangible Assets [Abstract]                    
Amortization of intangible assets     $ 2,400 $ 2,200 $ 7,200 $ 5,200        
GSK [Member]                    
Intangible Assets [Abstract]                    
Milestone payable               $ 126,000 £ 100.0  
Milestone amount paid   $ 126,000                
Welichem Biotech Inc. [Member]                    
Intangible Assets [Abstract]                    
Milestone payable               $ 20,000   $ 25.0
Milestone amount paid $ 20,000